Mutant BR96 antibodies reactive with human carcinomas
US5728821A · kind A · utility
10Cited by
11References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 1994 |
| Grant date | Mar 17, 1998 |
| Priority date | — |
| Expiry date | Aug 4, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides mutant BR96 polypeptides (and nucleotide sequences encoding them) having a variable region comprising an amino acid sequence derived from the variable region of BR96.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.